Related Experiment Videos
Three year anatomic, functional and clinical follow-up after successful percutaneous transluminal coronary
Insights
Long-term follow-up of percutaneous transluminal coronary angioplasty (PTCA) shows sustained improvements in coronary stenosis severity and exercise capacity. Functional outcomes remain positive for at least three years post-procedure.
Area of Science:
- Cardiology
- Interventional Cardiology
- Medical Imaging
Background:
- The long-term effects of percutaneous transluminal coronary angioplasty (PTCA) on coronary artery anatomy and cardiac function are not fully understood.
- Successful PTCA aims to reduce coronary stenosis and improve myocardial perfusion.
- Assessing the durability of PTCA's benefits is crucial for patient management.
Purpose of the Study:
- To evaluate the long-term anatomic and functional outcomes of successful single-lesion PTCA.
- To determine if the initial success of PTCA is maintained over a 3-year period.
- To assess changes in coronary stenosis, exercise tolerance, and left ventricular function post-PTCA.
Main Methods:
- Follow-up evaluations included coronary angiography, treadmill exercise testing, and radionuclide angiography.
- 46 patients with successful single-lesion PTCA were assessed at baseline, immediately after, 6 months, and 3 years.
- Measurements included diameter stenosis, exercise time, left ventricular ejection fraction, and Canadian Heart Association functional class.
Main Results:
- Coronary stenosis significantly decreased post-PTCA, from 66% to 19% at 3 years.
- Exercise time increased substantially after PTCA and was maintained at 3 years.
- Left ventricular ejection fraction during exercise improved post-PTCA and remained elevated.
- Patient functional class improved significantly, with most patients in class 0 or I at 3 years.
Conclusions:
- The anatomic success of PTCA in reducing coronary stenosis is maintained for at least 3 years.
- Functional improvements in exercise capacity and left ventricular function following PTCA are sustained long-term.
- PTCA offers durable benefits for patients with single-lesion coronary artery disease.
Abstract:
Because the long-term anatomic effects of percutaneous transluminal coronary angioplasty are unknown, follow-up evaluations including coronary angiography, treadmill exercise testing and rest and bicycle exercise radionuclide angiography were performed in 46 patients 6.3 +/- 2.0 and 37.6 +/- 3.6 (mean +/- SD) months after they had undergone successful single lesion angioplasty. The severity of the coronary stenosis decreased significantly at each evaluation; the mean diameter stenosis was 66 +/- 13% before angioplasty, 30 +/- 13% immediately after and 26 +/- 16% and 19 +/- 13% at 6 months and 3 years, respectively. Exercise time increased from 9.8 +/- 4.4 minutes before angioplasty to 18.3 +/- 4.5 minutes immediately after the procedure and remained at that level at 6 months (20.3 +/- 4.6 minutes) and 3 years (18.2 +/- 4.5 minutes). Left ventricular ejection fraction during exercise decreased 4 +/- 6% compared with rest before angioplasty, but increased 7 +/- 7% immediately after angioplasty and this increase was maintained at 6 months (+/- 6 +/- 7%) and 3 years (+/- 4 +/- 6%). Before angioplasty, 1 patient was in Canadian Heart Association functional class 0, 15 were in class II, 24 in class III and 6 in class IV. Three years later, 25 were in class 0, 10 in class I, 7 in class II and 4 in class III. These results indicate that the short-term anatomic and functional success of coronary angioplasty is maintained for at least 3 years.